Global Flow Chemistry Market for Pharmaceutical, Chemical, Academic & Industrial Research

Global Flow Chemistry Market for Pharmaceutical, Chemical, Academic & Industrial Research Transparency Market Research has published a new report titled “Flow Chemistry Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 – 2020.”

According to the report, the global flow chemistry market was valued at US$ 808.6 Mn in 2013 and is projected to reach US$ 1,526.3 Mn in 2020, expanding at a CAGR of 9.5% between 2014 and 2020.

Request for Sample@ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2058 Browse the full Flow Chemistry (Microreactor Systems, Continuous Stirred Tank Reactor, Plug Flow Reactor and Other Products) Market for Pharmaceutical, Chemical, Academic & Industrial Research, Petrochemical and Other End-user Industries – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 – 2020 The market for flow chemistry is primarily driven by factors such as increasing need to lower operating costs and adoption of sustainable technologies by chemical and pharmaceutical manufacturers. Flow chemistry offers various advantages over traditional batch processes. These include significant savings in energy usage, high scalability and continuous processing with high reactor throughput and superior heat and mass transfer. Flow chemistry also offers eco-friendly, low emission and a safe production process, thereby supporting green manufacturing.

Request for Brochure@ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2058 Continuous stirred tank reactor (CSTR) dominated the flow chemistry market in 2013. However, microreactor systems is anticipated to be the fastest growing segment during the forecast period.

Chemical was the largest end-user segment in the flow chemistry market in 2013.

Pharmaceutical is estimated to be the most lucrative end-user for flow chemistry in the next few years. However, scaling-up issues coupled with the need to conform to governmental regulations in the pharmaceutical industry are likely to hamper market growth in the near future.